MCH ADVISORY EQUITY RESEARCH
Institutional research — not investment advice ← Library
TXN HOLD REF $293 PW TARGET $280 (-5% vs spot · 12m PWEV) -4% Single-name research · 8 July 2026
Equity ResearchInformation Technology · Semiconductors
TXN

Texas Instruments Incorporated (TXN)

HOLD. 12-month probability-weighted target $280 (-4% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

Verdict
HOLD
Triangulated fair value $243 (-17% vs spot · triangulated FV)
Reference
$293
Close · 8 July 2026
PW Target
$280 (-5% vs spot · 12m PWEV) -4%
Probability-weighted
Horizon
12 mo
MCH Advisory
$243 (-17% vs spot · triangulated FV)
Fair value
$280 (-5% vs spot · 12m PWEV)
Scenario PWEV
41.0x
Forward P/E
$293B
Market cap
$151–$334
52-week range
Contents

Rating: HOLD

HOLD (5-tier) · cyclical compounder · conviction: medium

Metric Value
Current Price $293
Triangulated Fair Value $243 (-17% vs spot · triangulated FV)
12-mo Scenario PWEV $280 (-5% vs spot · 12m PWEV)
Forward P/E 41.0x
Market Cap $293B
52-Week Range $151–$334

EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).


Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-27. Each chart below sits with the part of the thesis it evidences.

General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.

Investment Committee Summary

Rating HOLD · HOLD (5-tier)
Classification · conviction cyclical compounder · medium
Triangulated fair value $243 (-17% vs spot · triangulated FV)
12-mo scenario PWEV $280 (-5% vs spot · 12m PWEV)
Next catalyst 2026-02-10 — Capital-management / capex framework update (analyst day cadence)
Primary thesis-break Quarterly revenue year-on-year growth < -3% (midpoint of Cyclical -3% and Base 10% recovery paths, on a YoY basis) (2 consecutive prints)

📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.

Rating Bridge

Rating = HOLD because:

  • Probability-weighted scenario value implies -5% vs spot
  • Monte Carlo median implies -12% vs spot
  • DCF fair value implies -19% vs spot — but this is terminal-value sensitive (exit-multiple $237 vs Gordon $122, 49% apart), so it carries less weight
  • Bear case (Structural — AI-Capex Digestion / China / Export Controls) downside is -54% vs spot
  • Net: reward/risk of 0.3× is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.

Investment Thesis

At the 2026-06-27 spot of $298.07 on roughly 41x forward earnings, the market is paying a durable quality premium for TXN's analog/embedded franchise and its US-based 300mm fab build, pricing a clean mid-cycle recovery. The engine is less generous. Its probability-weighted target of $286.40 sits marginally below spot, so the rating is HOLD. The independent DCF anchors lower still: $216 on a 30x terminal, $112 on a Gordon terminal, because the capex-bridge charges $4.55B of FY2025 capex against only $2.0B of D&A and treats much of the build as not yet earning its cost of capital. That capex-versus-return gap, not near-term demand, is where the engine diverges from the tape. Peer forward multiples reinforce the caution: NVDA at 23x and MU near 11x make TXN's 41x look expensive for 10% modelled growth. The single most damaging risk is that the new fabs stay underutilised, so fixed-cost deleverage holds gross margin down while the multiple de-rates toward the deep-cyclical floor.

The dashboard below is the whole argument on one page: spot ($293) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Integrated dashboard. The five valuation anchors bracket the $293 spot from <img src=
Integrated dashboard. The five valuation anchors bracket the $293 spot from $147 to $280 — stretched — spot sits above the skeptical blend.

Anti-Thesis (The Real Bear Case)

The strongest bear case is the Semi Downturn state, which the cluster house view weights most heavily. AI-capex digestion and export-control loss of China demand remove a structural slice of the addressable market just as TXN carries the depreciation and interest load of a multi-year 300mm build. Utilisation on the new fabs stays low, fixed-cost deleverage drags gross margin below 55%, and operating margin compresses toward the mid-30s. With roughly 79% of target variance attributable to the multiple, the market strips the quality premium and re-rates the franchise toward a deep-cyclical 30x. Earnings and the multiple fall together, and the target settles below the 52-week low of $150.97.

Key Debate

P/E Multiple explains 79% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q1): management +0.36 vs analyst floor +0.00 → delta +0.36 (n=43 mgmt / 18 Q&A; 45th pctile across the S&P book, z -0.2).

Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.

Quarter Mgmt Analyst Delta
2026Q1 +0.36 +0.00 +0.36
2025Q4 +0.38 +0.33 +0.05
2025Q3 +0.22 +0.03 +0.19
2025Q2 +0.19 +0.01 +0.18

News (last 365d, 1000 articles): avg ticker sentiment +0.18 (bullish 22% / bearish 3%)

Scenario Analysis

The tree runs from a structural 'Structural — AI-Capex Digestion / China / Export Controls' downside ($135) to a 'Bull — Supercycle Re-Rate' bull case ($487); the probability-weighted blend (PWEV $280) is -5% versus spot.

Scenario Probability Target Return vs spot
Structural — AI-Capex Digestion / China / Export Controls 20% $135 -54%
Cyclical Downturn — Inventory Correction 17% $214 -27%
Base — Mid-Cycle + AI Content 35% $290 -1%
Upcycle — AI / Datacenter Demand 20% $380 +30%
Bull — Supercycle Re-Rate 8% $487 +66%
Probability-Weighted (PWEV) $280 -5%

Scenario rationale — what each probability buys (the driver path behind every target):

  • Structural — AI-Capex Digestion / China / Export Controls (20%, $135). Structural impairment — AI-capex digestion / China / export controls: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 126.02; probability: 0.2.
  • Cyclical Downturn — Inventory Correction (17%, $214). Cyclical downturn — chip demand (AI/datacenter, auto, mobile) + the semi cycle + China / export controls weakens for 1–2 years before normalising. Drivers — implied_target: 214.0; probability: 0.17.
  • Base — Mid-Cycle + AI Content (35%, $290). Mid-cycle — normalised chip demand (AI/datacenter, auto, mobile) + the semi cycle + China / export controls; disciplined capital allocation; steady returns. Drivers — implied_target: 297.22; probability: 0.35.
  • Upcycle — AI / Datacenter Demand (20%, $380). Upside — AI + datacenter demand supercycle lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 401.25; probability: 0.2.
  • Bull — Supercycle Re-Rate (8%, $487). Upside tail — sustained tight conditions or a structural re-rate on AI + datacenter demand supercycle. Drivers — implied_target: 506.76; probability: 0.08.
Five-scenario tree. Probability-weighted targets around the $293 spot; PWEV $280 (-5% vs spot · 12m). the payoff shows modest negative expectancy — downside mass dominates (range <img src=
Five-scenario tree. Probability-weighted targets around the $293 spot; PWEV $280 (-5% vs spot · 12m). the payoff shows modest negative expectancy — downside mass dominates (range $135–$487)

Valuation Triangulation

Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.

Method Basis Fair Value vs Spot
Monte Carlo median (Student-t + regime) multiple $257 -12%
Peer P/E re-rate multiple $147 -50%
Peer EV/Revenue re-rate multiple $300 +2%
Scenario PWEV multiple $280 -5%
DCF (5-year + terminal) cash flow + terminal × $237 -19%
Triangulated (weighted) $243 -17%

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

Rating vs blend — the key debate. The rating tracks the multiple-discipline fair value (Monte Carlo $257 + scenario PWEV $280, ≈ spot); the weighted blend $243 (-17%) sits below it because the cash-flow DCF ($237) is materially more conservative than the market multiple. Whether the current multiple is justified is the central question for this name — and the principal downside risk to the rating.

Monte Carlo — the distribution, not a point

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $257 and 38% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (79% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.

Monte Carlo distribution. Median $257; P(price > current) 38%. P10–P90: <img src=
Monte Carlo distribution. Median $257; P(price > current) 38%. P10–P90: $143–$436.

DCF — the cash-flow anchor

Independent of the market multiple: a 5-year path, WACC 10.0%, 30x terminal FCF multiple → $237. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.

Independent DCF. WACC 10.0%, 30x terminal → $237.
Independent DCF. WACC 10.0%, 30x terminal → $237.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median forward multiple (P/E 20.53x) implies $147. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.

Cross-sectional peer benchmarking. Peer-median fwd P/E 20.53x → <img src=
Cross-sectional peer benchmarking. Peer-median fwd P/E 20.53x → $147; EV/Rev re-rate → $300.

Across all anchors the spread is 60% of the median — wide (genuine disagreement — the blend carries low valuation confidence).

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Segment Revenue Mix Growth Op margin EBIT Multiple Capex % Tag
Semiconductors $18.4B 100% 10% 42% $7.6B 40x 10% ESTIMATE
EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed).

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Dimension Assessment
driver chip demand (AI/datacenter, auto, mobile) + the semi cycle + China / export controls
net_debt_or_cash_b -10.5

Capital intensity & shareholder returns (ESTIMATE)

Dimension Assessment
capex_pct_revenue 0.1
div_yield 0.0183

Structural risk vs optionality (INFERENCE)

Dimension Assessment
downside AI-capex digestion / China / export controls
upside AI + datacenter demand supercycle

Industry Context — Information Technology — Semis

This name sits in the Information Technology — Semis as a semiconductors. chip demand (AI/datacenter, auto, mobile) + the semi cycle + China / export controls Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.

Value chain: AVGO (semiconductors) · AMD (semiconductors) · INTC (semiconductors) · AMAT (semi_equipment) · KLAC (semi_equipment) · TXN (semiconductors) · MRVL (semiconductors) · QCOM (semiconductors) · ADI (semiconductors) · NXPI (semiconductors) · MPWR (semiconductors) · TER (semi_equipment) · MCHP (semiconductors) · ON (semiconductors) · Q (semi_equipment) · SWKS (semiconductors)

Shared state Capex path House view This name implies
Semi Downturn — AI-Capex Digestion / China 37% 37%
Mid-Cycle — Normalised + AI Content 35% 35%
Upcycle — AI / Datacenter Supercycle 28% 28%

Mapping note: name-level 'Structural — AI-Capex Digestion / China / Export Controls' (20%) + 'Cyclical Downturn — Inventory Correction' (17%) map to cluster Semi Downturn — AI-Capex Digestion / China (37%); name-level 'Upcycle — AI / Datacenter Demand' (20%) + 'Bull — Supercycle Re-Rate' (8%) map to cluster Upcycle — AI / Datacenter Supercycle (28%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.

On the cluster's key downside — Semi Downturn — AI-Capex Digestion / China () — this name implies 37% vs the cluster house view of 37% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.

Structure: Shared State — The it_semis cycle is the shared macro driver. Driver — chip demand (AI/datacenter, auto, mobile) + semi cycle + WFE capex + China/export controls Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).

Model Appendix

DCF — line items

Year Revenue Op income − Capex + D&A FCF PV(FCF)
FY+1 $20B $9B $4B $5B $8B $7B
FY+2 $22B $10B $4B $4B $9B $7B
FY+3 $24B $11B $4B $4B $10B $8B
FY+4 $25B $12B $4B $4B $11B $7B
FY+5 $27B $13B $3B $4B $11B $7B
Terminal $11B × 30x $211B

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 10% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 10.0% · Σ PV(FCF) $36B + PV(terminal) $211B = EV $247B; + net cash → equity $237B ÷ diluted shares 1.00B = $237/share (exit-multiple terminal).

  • Gordon (perpetuity-growth) terminal at 2.5% → $122/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
  • Incremental ROIC on the forecast capex ≈ 15% vs WACC 10% → above WACC — the build is value-creative.

Peer set

Peer EV/Rev Fwd P/E Growth Op margin
NVDA 18.75x 22.68x 10% 66%
AVGO 24.69x 33.0x 10% 49%
MU 14.96x 10.54x 10% 68%
QCOM 4.8x 18.38x 10% 22%
Median 16.855x 20.53x

Peer-median fwd P/E → $147; EV/Rev → $300.

Weighted fair-value math

Anchor Value Weight Contribution
DCF $237 41% $98
Scenario PWEV $280 29% $82
Monte Carlo median $257 18% $45
Peer P/E $147 12% $17
Triangulated 100% $243

Sensitivity

DCF/share — WACC × terminal multiple

WACC \ Term× 21.0x 25.5x 30.0x 34.5x 39.0x
8% $190 $225 $260 $294 $329
9% $182 $215 $248 $281 $314
10% $174 $205 $237 $269 $301
11% $166 $197 $227 $257 $287
12% $159 $188 $217 $246 $275

DCF/share — revenue CAGR Δ × op-margin Δ

CAGRΔ \ MgnΔ -3.0pp -1.5pp +0.0pp +1.5pp +3.0pp
-3.0pp $195 $202 $208 $215 $221
-1.5pp $208 $215 $222 $229 $236
+0.0pp $222 $230 $237 $245 $252
+1.5pp $237 $245 $253 $261 $269
+3.0pp $252 $261 $269 $278 $286

Tornado — DCF/share swing by driver (widest first)

Driver Low High Swing
Terminal × ±15% $205 $269 $63
Revenue CAGR ±3pp $208 $269 $61
Op margin ±3pp $222 $252 $30
Capex intensity ±15% $226 $249 $23
WACC ±1pp $227 $248 $21

Company lever — SoP/share vs Semiconductors multiple (AI re-rating) (base 40x)

Multiple 28.0x 34.0x 40.0x 46.0x 52.0x
SoP/share $508 $619 $730 $841 $952

Consensus & Market Expectations

Reference Value
Street target (mean) $298 (+2% vs spot · street)
House target $286 (-3.9% vs street)
Sell-side coverage 37 analysts (SB 2 / B 15 / H 18 / S 2 / SS 0; net score 0.23)
Consensus FY EPS $8.95; house below (-20.0%)
Consensus FY revenue $23.3B; house below (-13.0%)

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Balance Sheet & Liquidity

Metric Value
Net debt $10.5B — modestly levered
Net debt / EBITDA 1.21x
Interest coverage (EBIT / interest) 11.5x
Current ratio 4.35x
Cash & ST investments $4.9B

Balance-sheet data as of 2025-12-31 (Alpha Vantage).

Capital Allocation

Metric Value
Free cash flow $2.6B
Buybacks / dividends $1.5B / $5.0B
Total shareholder yield 2.2%
Payout as % of FCF 248.8%
Reinvestment (capex / OCF) 63.6%
SBC as % of FCF 16.1%
Allocation stance returning more than FCF (balance-sheet funded)

Free-Cash-Flow Quality

Metric Value
FCF margin 14.1%
FCF conversion (FCF / net income) 52.0%
FCF yield 0.9%
Capex intensity (capex / revenue) 24.7%
FCF − SBC (diagnostic) $2.2B
Capex split (maint / growth) 25% / 75% — Heavy builder: ~10% capex/rev in a multi-year 300mm fab expansion far above D&A; the growth tilt is the source of the FCF/ROIC dilution the engine flags.

Accounting quality: SBC 2.3% of revenue; cash conversion (OCF/NI) 143% — cash-backed.

Catalyst Calendar

  • 2026-02-10 (~-148d) — Capital-management / capex framework update (analyst day cadence) (authored)
  • 2026-07-22 (~14d) — Quarterly earnings — est. EPS $1.90 (AV EARNINGS_CALENDAR)
  • 2026-07-31 (~23d) — SM1/LFAB 300mm fab utilisation ramp checkpoint (authored)
  • 2027-01-31 (~207d) — CHIPS Act incentive / ITC realization milestone (authored)

Forecast Track Record

  • EPS surprise: beat 75.0% of the last 8 quarters; average surprise +8.3%.

Competitive Moat

Wide moat. The moat is genuinely wide — an unmatched analog/embedded catalog (~80k+ parts), owned 300mm US fabs (lowest unit cost), direct sales/distribution reach and decades-long design-in stickiness — which justifies a premium terminal multiple ABOVE the market. But at ~40x the capex-bridge shows $4.55B FY25 capex against only ~$2.0B D&A, so the multiple is hostage to fab utilisation, not moat quality. Falsifiable: if new-fab utilisation stays low and gross margin holds below 55% through the cycle, incremental returns fail cost of capital and even a wide moat cannot support 40x — it should compress toward high-20s/30x.

Moat sources:

  • Broadest analog/embedded product catalog with long design-in lifecycles (auto/industrial sockets)
  • Owned 300mm US wafer fabs = structural unit-cost advantage vs fabless/foundry peers
  • Direct sales + largest catalog distribution reach (TI.com) — proprietary channel
  • In-house manufacturing + geographic diversification (US CHIPS-supported build)
Issue Probability Valuation sensitivity Horizon
US-China export controls / China analog demand loss and domestic-substitution acceleration high (~55%) high - China is a material end-market; structural share loss ~10-15% of FV 12-24m
CHIPS Act incentive execution / tariff regime on semiconductors (net could be positive) medium (~50%) medium - incentive timing swings FCF/ROIC on the build ~5-8% of FV 12-24m

Probabilities and sensitivities are analyst estimates, not market-implied.

Scenario Macro & Key Risks

Scenario Macro assumption Key risk
Structural — AI-Capex Digestion / China / Export Controls AI-capex digestion plus export-control-driven loss of China demand removes a structural slice of the addressable analog market. Low new-fab utilisation carries full depreciation/interest load — fixed-cost deleverage pushes gross margin below 55% and compresses earnings AND multiple.
Cyclical Downturn — Inventory Correction Broad-based semiconductor inventory correction (auto/industrial/mobile) softens demand for 1-2 years before normalising. The capex ramp continues into a demand trough, so FCF is thin exactly when utilisation falls.
Base — Mid-Cycle + AI Content Mid-cycle analog demand recovery with rising AI/datacenter analog content; disciplined capital returns. Even mid-cycle, the $4.55B capex vs ~$2.0B D&A gap keeps DCF fair value well below a 40x tape.
Upcycle — AI / Datacenter Demand AI/datacenter and broad-industrial upcycle lifts analog content and fab utilisation above trend. Requires the new 300mm capacity to fill quickly — utilisation timing is the load-bearing variable.
Bull — Supercycle Re-Rate Analog supercycle with sustained pricing and US-manufacturing scarcity premium re-rates the franchise. Prices a durable supercycle and full-utilisation payoff on the build the current capex-bridge does not credit.

What the Market Is Pricing In

At the current price, the market pays 32.8× forward EPS, vs the house DCF terminal 30.0×, and a peer median 20.53×. The house DCF sits 19% below spot, so the market is pricing in more than the house case — roughly 2.2pp of revenue CAGR.

Variant perception: the house view is below-consensus, and the thesis is primarily event-driven.

Metric Consensus House Importance
Revenue 23.3 20.3 High
EPS 8.9 7.2 Medium
Target price 298.0 286.4 Medium

Peer Quality & Weighting

Peer Fwd P/E Growth Op margin Quality Weight cap
NVDA 22.68× 10% 66% segment 50%
AVGO 33.0× 10% 49% direct 100%
MU 10.54× 10% 68% broad 25%
QCOM 18.38× 10% 22% segment 50%

Quality-weighted forward P/E: 25.0× (simple median 20.53×). Direct peers count 100%, segment 50%, broad 25%.

Historical-range cross-check: 52-week range $151–$334, centre $225 (-23% vs spot); spot sits at the 78th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

Metric Value
Upside to triangulated FV $243 (-17% vs spot · triangulated FV)
Downside to bear case (Structural — AI-Capex Digestion / China / Export Controls) $135 (-54% vs spot · bear scenario)
Reward/risk ratio 0.3×
Margin of safety (FV vs spot) -21%
P(price > spot) — Monte Carlo 38%

Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Bull — Supercycle Re-Rate): $487.

Assumption Register

Assumption Value Used in Source
WACC 10.0% DCF discount rate estimate (CAPM)
Terminal multiple 30× DCF exit value estimate (peer-anchored)
Terminal growth 2.5% DCF Gordon terminal estimate
SBC dilution 0.0%/yr PWEV, MC, DCF (charged once) estimate (from SBC/rev)
EPS basis consensus forward EPS (broker-adjusted, non-GAAP) all forward P/E & scenario multiples definition

Sensitivity-ranked drivers (widest fair-value swing first): Terminal × ±15% (63.0); Revenue CAGR ±3pp (61.0); Op margin ±3pp (30.0); Capex intensity ±15% (23.0); WACC ±1pp (21.0).

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Input Value Type Source Confidence Used in
Revenue TTM $18.4B reported fact 10-K/10-Q via AV High Forecast base, EV/Rev
FY+1 guided revenue $20.3B company guidance Company guidance Medium Forecast, SoP
Consensus FY EPS $8.948 consensus estimate Sell-side consensus via AV Medium Variant perception
Diluted shares 0.999B reported fact 10-K via AV High Market cap, per-share
Net debt / cash $10.51B reported fact Balance sheet via AV High EV, DCF equity bridge
WACC 10.0% house estimate CAPM (beta/rf) Medium DCF discount rate
Terminal multiple 30× house estimate Peer/historical range Medium DCF exit value
Terminal growth 2.5% house estimate Long-run GDP+ Medium DCF Gordon terminal

Source Log

Source Type Date Used for Reference
Alpha Vantage — GLOBAL_QUOTE / OVERVIEW market data 2026-07-08 Price, market cap, EV, 52-week range, forward P/E Alpha Vantage 2026-06-27
Company income statement (10-K / 10-Q) via Alpha Vantage reported fact 2026-07-08 Revenue, gross/operating margin, EBIT, interest expense INCOME_STATEMENT / latest annual
Company balance sheet (10-K / 10-Q) via Alpha Vantage reported fact 2026-07-08 Cash, debt, net debt, leases, equity, coverage BALANCE_SHEET / latest annual
Company cash-flow statement (10-K / 10-Q) via Alpha Vantage reported fact 2026-07-08 Operating cash flow, capex, FCF, buybacks, dividends, SBC CASH_FLOW / latest annual
Company earnings releases via Alpha Vantage reported fact 2026-07-08 Reported EPS, surprise history EARNINGS / quarterly
Sell-side consensus via Alpha Vantage consensus estimate 2026-07-08 Forward revenue/EPS consensus, analyst count EARNINGS_ESTIMATES
Earnings calendar via Alpha Vantage market data 2026-07-08 Next earnings date, catalyst timing EARNINGS_CALENDAR
Company guidance company guidance 2026-07-08 FY guided revenue / non-GAAP EPS basis company guidance / earnings call
MCH segment model (from filings & disclosures) house estimate 2026-07-08 Segment revenue, margins, multiples, AI decomposition company_context (authored, tagged)
MCH qualitative analysis inference 2026-07-08 Moat, regulatory risk, scenario macro, catalysts company_context enrichment (authored)
MCH investment thesis & falsification triggers house estimate 2026-07-08 Thesis, anti-thesis, thesis-break signals authored §5.3

Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.

Load-Bearing Assumptions

DCF: WACC 10%, terminal multiple 30×, FY+5 revenue $27B. Triangulation leans 41% on DCF, 29% on PWEV.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

  • Quarterly revenue year-on-year growth < -3% (midpoint of Cyclical -3% and Base 10% recovery paths, on a YoY basis) (2 consecutive prints → Semi Downturn — AI-Capex Digestion / China). Two straight quarters of YoY revenue decline signal the inventory correction is deepening past a one-quarter dip toward the Cyclical or Structural path, invalidating the Base recovery assumption.
  • Gross margin < 55% (well below the ~58-60% mid-cycle level; the new-fab deleverage line) (2 consecutive prints → Semi Downturn — AI-Capex Digestion / China). Sustained sub-55% gross margin would confirm fixed-cost deleverage on the underutilised 300mm fabs is structural, pointing at the compressed operating-margin assumption in the Structural path rather than a transient trough.
  • Fab utilisation / free-cash-flow per share < $5.00 FCF/share trailing-twelve-month (against the historically higher pre-build level) (2 consecutive prints → Semi Downturn — AI-Capex Digestion / China). If elevated capex ($4.55B FY2025 against $2.0B D&A) does not convert to rising cash generation, the fab build is value-dilutive and the DCF capex-bridge penalty deepens, undermining the Base target.
  • China revenue contribution or an incremental US export-control action affecting analog/embedded shipments >= a new binding restriction or China revenue falling below the low-teens percent of total (single event → Semi Downturn — AI-Capex Digestion / China). A discrete tightening of export controls or a step-loss of China demand would remove a structural slice of the addressable market, moving weight from the Cyclical path toward the Structural path.
  • Forward P/E multiple < 33x (the Cyclical-path multiple, versus the ~41x Base premium) (2 consecutive prints → Semi Downturn — AI-Capex Digestion / China). The Monte Carlo attributes ~79% of target variance to the multiple. A durable de-rating below the mid-cyclical 33x line signals the market has abandoned the quality premium embedded in the Base and higher scenarios.

Fact / Inference / Speculation

  • FACT: Spot $293; 52-week range $151–$334; engine rating HOLD; base-case target $286 (-2%). (source: Alpha Vantage 2026-06-27, 8 July 2026)
  • INFERENCE: Triangulated FV $243 (-17% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
  • SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.

Recommendation: HOLD

Balanced: triangulated fair value $243 (-17% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.

Disclosures & Limitations

This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.

  • No suitability assessment has been performed for any individual.
  • Market data may be delayed or inaccurate; figures are as of the analysis date.
  • Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
  • Forecasts are uncertain; past performance is not indicative of future returns.
  • The author or publisher may hold positions in securities mentioned.
  • Users should verify information against primary sources (company filings) before acting.
  • Investing involves risk of loss; there is no guarantee any target price is achieved.
  • Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.
Disclosures. This document is produced by MCH Advisory Services for informational and quantitative-research purposes only. It does not constitute investment, financial, legal or tax advice, nor an offer or solicitation to buy or sell any security. Price targets and probabilities are model outputs, not guarantees; past performance and backtested/simulated figures are not reliable indicators of future results. The author may hold positions in instruments mentioned and is not a registered financial adviser. Conduct your own due diligence and consult a qualified, registered adviser before making any investment decision.